Could the results of the immunogenicity mice study be delayed to coincide with the ipo of ngio?.....that is a possibility....i think it will be detrimental to come out with a 'complete vaccine' and the company is still not on the nasdaq....i mean it is registered with the sec....but not yet 'churning'.....what do you all think?...
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links